Importantly, tissue analyses revealed the presence of Slit2-expressing fibroblasts in breast tumor tissue thus validating the relevance of these CAFs in human disease and suggesting Slit2 as a potential effector of this tumor-inhibitory CAF-subtype. This evidence concerns the gene SLIT2 and neoplasm.